PDMA Director Assumes Role As MHLW Assistant Vice Minister For Pharmaceutical Affairs
This article was originally published in PharmAsia News
Executive Summary
Japan's Pharmaceutical and Medical Device Agency Director Shuichi Kishida assumed the position of Assistant Vice Minister for Pharmaceutical Affairs at the Ministry of Health, Labor and Welfare, Sept. 1. Former Assistant Vice Minister Tatsuo Kurokawa resigned on the same day. A graduate of Osaka University's graduate school in pharmaceutical science, Kishida entered the MHLW in 1974. In 2003, he became a director for the Pharmaceutical and Food Safety Bureau and a director in charge of safety measures for the PDMA in 2004. He became a board director for the PDMA in 2006. (Click here for more - Japanese language)
You may also be interested in...
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.